Literature DB >> 22383753

Natural killer cell tolerance: control by self or self-control?

Baptiste N Jaeger1, Eric Vivier.   

Abstract

A major challenge for the immune system is to control pathogens and stressed cells, such as infected or tumors cells, while sparing healthy self-cells. To achieve this tolerance to self, immune cells must recognize and differentiate "self" versus "nonself" and "self" versus "altered self." In the absence of self-tolerance, cells of the adaptive immune system attack healthy cells and cause autoimmune diseases such as lupus, psoriasis, and type I diabetes. Mechanisms at work to ensure tolerance in the innate immune system are still poorly understood. Natural killer cells are innate immune lymphocytes, which have the capacity to kill cellular targets and produce cytokines without prior specific sensitization. Because of these intrinsic effector capacities, tolerance mechanisms must exist to prevent autoreactivity. Herein, we will review the present knowledge on NK cell tolerance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383753      PMCID: PMC3282405          DOI: 10.1101/cshperspect.a007229

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  55 in total

Review 1.  Missing self recognition and self tolerance of natural killer (NK) cells.

Authors:  David H Raulet
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

Review 2.  Licensing of natural killer cells by self-major histocompatibility complex class I.

Authors:  Wayne M Yokoyama; Sungjin Kim
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

3.  NK cell education: not an on-off switch but a tunable rheostat.

Authors:  Petter Brodin; Klas Kärre; Petter Höglund
Journal:  Trends Immunol       Date:  2009-03-11       Impact factor: 16.687

4.  Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo.

Authors:  Caroline Sola; Pascale André; Céline Lemmers; Nicolas Fuseri; Cécile Bonnafous; Mathieu Bléry; Nicolai R Wagtmann; François Romagné; Eric Vivier; Sophie Ugolini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

5.  Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance.

Authors:  Sophie Guia; Baptiste N Jaeger; Stefan Piatek; Sébastien Mailfert; Tomasz Trombik; Aurore Fenis; Nicolas Chevrier; Thierry Walzer; Yann M Kerdiles; Didier Marguet; Eric Vivier; Sophie Ugolini
Journal:  Sci Signal       Date:  2011-04-05       Impact factor: 8.192

6.  The activating receptor NKp46 is essential for the development of type 1 diabetes.

Authors:  Chamutal Gur; Angel Porgador; Moran Elboim; Roi Gazit; Saar Mizrahi; Noam Stern-Ginossar; Hagit Achdout; Hormas Ghadially; Yuval Dor; Tomer Nir; Victoria Doviner; Oren Hershkovitz; Michal Mendelson; Yaakov Naparstek; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

Review 7.  Innate or adaptive immunity? The example of natural killer cells.

Authors:  Eric Vivier; David H Raulet; Alessandro Moretta; Michael A Caligiuri; Laurence Zitvogel; Lewis L Lanier; Wayne M Yokoyama; Sophie Ugolini
Journal:  Science       Date:  2011-01-07       Impact factor: 47.728

8.  Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

Authors:  Jeffery S Miller; Sarah Cooley; Peter Parham; Sherif S Farag; Michael R Verneris; Karina L McQueen; Lisbeth A Guethlein; Elizabeth A Trachtenberg; Michael Haagenson; Mary M Horowitz; John P Klein; Daniel J Weisdorf
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

9.  Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells.

Authors:  Thushara P Abeyweera; Ernesto Merino; Morgan Huse
Journal:  J Cell Biol       Date:  2011-02-21       Impact factor: 10.539

10.  Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.

Authors:  Biljana Zafirova; Sanja Mandarić; Ronald Antulov; Astrid Krmpotić; Helena Jonsson; Wayne M Yokoyama; Stipan Jonjić; Bojan Polić
Journal:  Immunity       Date:  2009-07-23       Impact factor: 31.745

View more
  9 in total

Review 1.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Slp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets.

Authors:  Kristin Lampe; Mehari Endale; Siobhan Cashman; Hao Fang; Jochen Mattner; David Hildeman; Kasper Hoebe
Journal:  Eur J Immunol       Date:  2015-05-22       Impact factor: 5.532

3.  An ENU mutagenesis approach to dissect "self"-induced immune responses: Unraveling the genetic footprint of immunosurveillance.

Authors:  Siobhan Cashman; Kristin Lampe; Rachel Sheridan; Kasper Hoebe
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

Review 4.  The Janus Face of Death Receptor Signaling during Tumor Immunoediting.

Authors:  Eimear O' Reilly; Andrea Tirincsi; Susan E Logue; Eva Szegezdi
Journal:  Front Immunol       Date:  2016-10-31       Impact factor: 7.561

5.  HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation.

Authors:  Josefa A Rodríguez
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

6.  Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.

Authors:  Franziska Brauneck; Elisa Seubert; Jasmin Wellbrock; Julian Schulze Zur Wiesch; Yinghui Duan; Tim Magnus; Carsten Bokemeyer; Friedrich Koch-Nolte; Stephan Menzel; Walter Fiedler
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 7.  Cytokine-induced memory-like natural killer cells for cancer immunotherapy.

Authors:  Mubin Tarannum; Rizwan Romee
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 6.832

Review 8.  Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches.

Authors:  Sebastian Carotta
Journal:  Front Immunol       Date:  2016-04-21       Impact factor: 7.561

9.  Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device.

Authors:  Constanca Figueiredo; Dorothee Eicke; Yuliia Yuzefovych; Murat Avsar; Jasmin Sarah Hanke; Michael Pflaum; Jan-Dieter Schmitto; Rainer Blasczyk; Axel Haverich; Bettina Wiegmann
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.